Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Upstream Bio, Inc. (UPB) Insider Trading Activity
Healthcare • Biotechnology • 38 employees
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.
Total Value
$48,025,000.00
Total Shares
2,825,000
Average Trade Value
$9,605,000.00
Most Active Insider
Ai Upstream Llc
Total Activity: $19,975,000
Largest Single Transaction
$19,975,000
by Ai Upstream Llc on Oct 15, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Director, 10% Owner
|
Oct 15, 2024 | 165,000 | $2,805,000 | 1,138,716 (+14.5%) | Purchase | |
Oct 15, 2024 | 1,175,000 | $19,975,000 | 1,175,000 (+100.0%) | Purchase | ||
Director, 10% Owner
|
Oct 15, 2024 | 660,000 | $11,220,000 | 4,554,873 (+14.5%) | Purchase | |
Director, 10% Owner
|
Oct 15, 2024 | 660,000 | $11,220,000 | 4,554,873 (+14.5%) | Purchase | |
Director, 10% Owner
|
Oct 15, 2024 | 165,000 | $2,805,000 | 1,138,716 (+14.5%) | Purchase |